1 |
Hernan MA, Lanoy E, Costagliola D, and Robins JM (2006). Comparison of dynamic treatment regimes via inverse probability weighting, Basic & Clinical Pharmacology & Toxicology, 98, 237-242.
DOI
|
2 |
Bertsekas D and Tsitsiklis J (1996). Neuro-Dynamic Programming, Athena Scientific, Massachusetts.
|
3 |
Henderson R, Ansell P, and Alshibani D (2010). Regret-regression for optimal dynamic treatment regimes, Biometrics, 66, 1192-1201.
DOI
|
4 |
Kravitz RL, Duan N, and Braslow J (2004). Evidence-based medicine, heterogeneity of treatment effects and the trouble with averages, Milbank Quarterly, 82, 661-687.
DOI
|
5 |
Lee BK, Lessler J, and Stuart EA (2010). Improving propensity score weighting using machine learning, Statistics in Medicine, 29, 337-346.
DOI
|
6 |
Longford NT and Nelder JA (1999). Statistics versus statistical science in the regulatory process, Statistics in Medicine, 18, 2311-2320.
DOI
|
7 |
Lu W, Zhang HH, and Zeng D (2011). Variable selection for optimal treatment decision, Statistical Methods in Medical Research, 22, 493-504.
DOI
|
8 |
Murphy SA (2003). Optimal dynamic treatment regimes (with discussions), Journal of the Royal Statistical Society: Series B, 65, 331-366.
DOI
|
9 |
Murphy SA (2005). A generalization error for q-learning, Journal of Machine Learning Research, 6, 1073-1097.
|
10 |
Polley E, LeDell E, Kennedy C, Lendle S, and van der Laan M (2016). Package 'superlearner', Retrieved from: https://cran.r-project.org/web/packages/SuperLearner/SuperLearner.pdf
|
11 |
Ridgeway G, McCaffrey D, Morral A, Griffin BA, and Burgette L (2016). Twang: toolkit for weighting and analysis of nonequivalent groups.
|
12 |
Thall PF, Millikan RE, and Sung HG (2000). Evaluating multiple treatment courses in clinical trials, Statistics in Medicine, 19, 1011-1028.
DOI
|
13 |
Chakraborty B (2011). Dynamic treatment regimes for managing chronic health conditions: a statistical perspective, American Journal of Public Health, 101, 40-45.
DOI
|
14 |
Robins JM, Orellana L, and Rotnitzky A (2008). Estimation and extrapolation of optimal treatment and testing strategies, Statistics in Medicine, 27, 4678-4721.
DOI
|
15 |
Sorensen TI (1996). Which patients may be harmed by good treatments?, Lancet, 348, 351-352.
DOI
|
16 |
Tian L, Alizaden AA, Gentles AJ, and Tibshirani R (2014). A simple method for estimating interactions between a treatment and a large number of covariates, Journal of the American Statistical Association, 109, 1517-1532.
DOI
|
17 |
Tibshirani R (1996). Regression shrinkage and selection via the lasso, Journal of the Royal Statistical Society: Series B, 58, 267-288.
|
18 |
Van der Laan MJ, Polley EC, and Hubbard AE (2007). Super learner, Statistical Applications in Genetics and Molecular Biology, 6.
|
19 |
Wallace MP and Moodie EEM (2015). Doubly-robust dynamic treatment regimen estimation via weighted least squares, Biometrics, 71, 636-644.
DOI
|
20 |
Westreich D, Lessler J, and Funk MJ (2010). Propensity score estimation: neural networks, support vector machines, decision trees (CART) and meta-classifiers as alternatives to logistic regression, Journal of Clinical Epidemiology, 63, 826-833.
DOI
|
21 |
Chakraborty B, Murphy SA, and Strecher V (2010). Inference for non-regular parameters in optimal dynamic treatment regimes, Statistical Methods in Medical Research, 19, 317-343.
DOI
|
22 |
Zhao P and Yu B (2006). On model selection consistency of lasso, Journal of Machine Learning Research, 7, 2541-2563.
|
23 |
Pineau J, Bellemare MG, Rush AJ, Ghizaru A, and Murphy SA (2007). Constructing evidence-based treatment strategies using methods from computer science, Drug and Alcohol Dependence, 88, 52-60.
|
24 |
Arjas E and Saarela O (2010). Optimal dynamic regimes: presenting a case for predictive inference, The International Journal of Biostatistics, 6.
|
25 |
Bellman R (1957). Dynamic Programming, Princeton University Press, Princeton.
|
26 |
Breiman L, Friedman JH, Olshen RA, and Stone CJ (1984). Classification and Regression Trees, Wadsworth, California.
|
27 |
Gunter L, Zhu J, and Murphy SA (2011). Variable selection for qualitative interactions, Statistical Methodology, 8, 42-55.
DOI
|
28 |
Kereiakes DJ, Obenchain RL, Barber BL, et al. (2000). Abciximab provides cost-effective survival advantage in high-volume interventional practice, American Heart Journal, 140, 603-610.
DOI
|
29 |
Robins JM, Hernan MA, and Brumback B (2000). Marginal structural models and causal inference in epidemiology, Epidemiology, 11, 550-560.
DOI
|
30 |
Geng Y, Zhang HH, and Lu W (2015). On optimal treatment regimes selection for mean survival time, Statistics in Medicine, 34, 1169-1184.
DOI
|
31 |
Wallace MP, Moodie EEM, and Stephens DA (2017). Model validation and selection for personalized medicine using dynamic-weighted ordinary least squares, Statistical Methods in Medical Research, 26, 1641-1653.
DOI
|
32 |
Robins JM (2004). Optimal structural nested models for optimal sequential decisions. In Proceedings of the Second Seattle Symposium on Biostatistics, Springer, New York.
|
33 |
Therneau T, Atkinson B, and Ripley B (2014). Package 'Rpart', Retrieved from: http://cran.r-project.org/web/packages/rpart/rpart.pdf
|
34 |
Van der Laan MJ and Petersen ML (2007). Causal effect models for realistic individualized treatment and intention to treat rules, The International Journal of Biostatistics, 3.
|
35 |
Zou H (2006). The adaptive lasso and its oracle properties, Journal of the American Statistical Association, 101, 1418-1429.
DOI
|